Home › Myasthenia Gravis › North Carolina › Durham
Myasthenia Gravis clinical trials in Durham, NC
10 studies for Myasthenia Gravis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RecruitingObservational study
- Duke Early Phase Clinical Research Unit - PPDS, Durham
- University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill · 10 mi away
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
RecruitingPhase 2
- Duke Early Phase Clinical Research Unit - PPDS, Durham
- University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill · 10 mi away
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
RecruitingPhase 3
- UNC Hospitals - PARENT, Chapel Hill · 10 mi away
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
RecruitingPhase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 10 mi away
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RecruitingPhase 3
- Duke University School of Medicine, Durham
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
RecruitingPhase 3
- University of North Carolina Hospitals - Neurology Clinic, Chapel Hill · 10 mi away
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
RecruitingObservational study
- Clinical Trial Site, Durham
- Clinical Trial Site, Chapel Hill · 10 mi away
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RecruitingHealthy volunteers welcome
- Duke University, Durham
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Miami, FL7 studies
- New York City, NY7 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- Boston, MA6 studies
- Washington, DC6 studies
- San Francisco, CA6 studies
- Orange, CA6 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.